Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-16-139279)

Filing Details

Accession Number:: 0001104659-16-139279
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-12 13:19:08
Reporting Period:: 2016-08-10

Filing Date:: 2016-08-12
Accepted Time:: 2016-08-12 13:19:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1638287	Gemphire Therapeutics Inc.	GEMP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1470741	Pedro Lichtinger	43334 Seven Mile Road Suite 1000 Northville MI 48167		Yes	No	No	No

Transaction Summary

Purchased:	10,000 shares	Avg. Price: $10.00	Total Value: $100,000.00
Number of Shares After Transactions:	49,274 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-10	39,274	$6.71	39,274	No	4	C	Direct
Common Stock	Acquisiton	2016-08-10	10,000	$10.00	49,274	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	8% Convertible Subordinated Promissory Note	Disposition	2016-08-10	0	$0.00	39,274	$6.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct

Footnotes

The note was issued in the original principal amount of $250,000. The outstanding principal and $13,370 of accrued interest on the note automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering.